Codiak BioSciences, Inc. (CDAK) financial statements (2022 and earlier)

Company profile

Business Address 35 CAMBRIDGEPARK DRIVE
CAMBRIDGE, MA 02140
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:76,90098,600113,700130,30088,91548,300
Cash and cash equivalents76,93898,584113,681130,27288,91548,339
Other undisclosed cash, cash equivalents, and short-term investments(38)161928 (39)
Prepaid expense2,593   2,598 
Deferred costs200   2001,660
Other undisclosed current assets10,4785,3135,6224,3772,0452,401
Total current assets:90,171103,913119,322134,67793,75852,361
Noncurrent Assets
Operating lease, right-of-use asset21,95721,25821,51921,76722,00322,226
Property, plant and equipment23,47929,38430,26330,88531,41031,544
Restricted cash and investments4,1704,1704,1704,1704,1704,170
Other noncurrent assets     50
Other undisclosed noncurrent assets31,893     
Total noncurrent assets:81,49954,81255,95256,82257,58357,990
TOTAL ASSETS:171,670158,725175,274191,499151,341110,351
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,54111,3139,4718,96710,88826,346
Accounts payable1,8381,9981,7822,1622,0182,488
Accrued liabilities9,7039,3157,6896,8058,87023,858
Deferred revenue12,9639,3529,1174,3455,2816,268
Other undisclosed current liabilities2,6612,4382,3332,2301,4821,778
Total current liabilities:27,16523,10320,92115,54217,65134,392
Noncurrent Liabilities
Long-term debt and lease obligation60,31460,01660,53661,02661,50061,927
Long-term debt, excluding current maturities25,43025,35225,23025,09524,96024,825
Operating lease, liability34,88434,66435,30635,93136,54037,102
Liabilities, other than long-term debt30,68641,39341,74646,00857,41658,069
Deferred revenue30,68641,39341,74646,00857,41658,069
Other undisclosed noncurrent liabilities 207207207207 
Total noncurrent liabilities:91,000101,616102,489107,241119,123119,996
Total liabilities:118,165124,719123,410122,783136,774154,388
Temporary equity, carrying amount     225,033
Stockholders' equity
Stockholders' equity attributable to parent53,50534,00651,86468,71614,567(269,070)
Common stock22222 
Additional paid in capital378,750375,913372,069367,112302,6551,063
Accumulated deficit(325,247)(341,909)(320,207)(298,398)(288,090)(270,133)
Total stockholders' equity:53,50534,00651,86468,71614,567(269,070)
TOTAL LIABILITIES AND EQUITY:171,670158,725175,274191,499151,341110,351

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Revenues7,6971,15789013,1911,640954
Sublease income662484348357366337
Gross profit:7,6971,15789013,1911,640954
Operating expenses(24,337)(22,653)(22,356)(23,138)(19,247)(35,982)
Operating loss:(16,640)(21,496)(21,466)(9,947)(17,607)(35,028)
Nonoperating income (expense)33,302(206)(343)(361)(350)(265)
Investment income, nonoperating33,29049574
Other nonoperating income617479352332353338
Interest and debt expense(605)(689)(704)(698)(710)(607)
Income (loss) before gain (loss) on sale of properties:16,057(22,391)(22,513)(11,006)(18,667)(35,900)
Other undisclosed net income605  698710 
Net income (loss):16,662(22,391)(22,513)(10,308)(17,957)(35,900)
Other undisclosed net income attributable to parent 689704  607
Net income (loss) attributable to parent:16,662(21,702)(21,809)(10,308)(17,957)(35,293)
Preferred stock dividends and other adjustments    (535)(3,457)
Net income (loss) available to common stockholders, diluted:16,662(21,702)(21,809)(10,308)(18,492)(38,750)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
Net income (loss):16,662(22,391)(22,513)(10,308)(17,957)(35,900)
Comprehensive income (loss):16,662(22,391)(22,513)(10,308)(17,957)(35,900)
Other undisclosed comprehensive income, net of tax, attributable to parent 689704  607
Comprehensive income (loss), net of tax, attributable to parent:16,662(21,702)(21,809)(10,308)(17,957)(35,293)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: